title: The effect of maternal restraint on developmental toxicity of aluminum in mice.
abstract: Both aluminum (Al) and maternal restraint have been reported to cause developmental toxicity in mammals. This study assessed in pregnant mice the potential interaction between Al and maternal restraint. Four groups of plug-positive female mice were given IP injections of AlCl3 at 37.5 and 75 mg/kg/day on days 6-15 of gestation. Two of these groups were also subjected to restraint for 2 h/day during the same gestational days. Control groups included restrained and unrestrained pregnant mice nonexposed to Al. Cesarean sections were performed on gestation day 18, and the fetuses were weighed and examined for morphological defects. Maternal toxicity was significantly enhanced by restraint at 75 mg AlCl3/kg/day. No increases in the number of resorptions or dead fetuses per litter were observed following exposure to Al, maternal restraint, or combined Al and restraint. However, a significant decrease in fetal body weight, as well as a significant increase in the number of litters with morphologic defects, was observed in the group exposed to 75 mg AlCl3/kg/day plus maternal restraint. The current results suggest that maternal restraint could enhance the metal-induced developmental toxicity (reduced fetal body weight, increase in the number of litters with morphologic defects) only at high doses of the metal, which are also toxic to the dam.
authors.affiliation: Department of Psychology, Rovira i Virgili University, Tarragona, Spain.
authors.forename: M T
authors.initials: MT
authors.lastname: Colomina
authors.forename: J L
authors.initials: JL
authors.lastname: Esparza
authors.forename: J
authors.initials: J
authors.lastname: Corbella
authors.forename: J L
authors.initials: JL
authors.lastname: Domingo
mesh_terms: D000077410:Aluminum Chloride; D017607:Aluminum Compounds / Q000633:toxicity*; D000818:Animals; D002712:Chlorides / Q000633:toxicity*; D000013:Congenital Abnormalities / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005327:Fetal Resorption / Q000209:etiology*; D007668:Kidney / Q000033:anatomy & histology / Q000187:drug effects; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology; D011297:Prenatal Exposure Delayed Effects; D012149:Restraint, Physical; D013312:Stress, Physiological / Q000150:complications*; D013723:Teratogens / Q000633:toxicity*; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects
chemical_list: D017607:Aluminum Compounds; D002712:Chlorides; D013723:Teratogens; D000077410:Aluminum Chloride